COMPOSITIONS AND METHODS FOR MODULATING AT2R ACTIVITY

New polypeptide agonists of AT2R are disclosed, as well as pharmaceutical compositions comprising the agonists, methods of their use in the treatment of diseases, conditions or disorders characterized by insufficient AT2R activity or excessive AT1R activity, and methods of their use as laboratory re...

Full description

Saved in:
Bibliographic Details
Main Authors SRINIVAS, Raja R, GAVINI, Madhavi P
Format Patent
LanguageEnglish
Published 03.01.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:New polypeptide agonists of AT2R are disclosed, as well as pharmaceutical compositions comprising the agonists, methods of their use in the treatment of diseases, conditions or disorders characterized by insufficient AT2R activity or excessive AT1R activity, and methods of their use as laboratory reagents for research purposes.
Bibliography:Application Number: US201816130820